Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) Current Cash

Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War) posts a current cash of $940K as of June 2026. That compares with $3.3M in the prior-year period — down 71.6% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s current cash was $3.3M. The latest reading is $940K — a 71.6% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

Current Cash is one piece of Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s financial statement story. At $940K, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PBAXU's current cash usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Phoenix Biotech Acquisition - Units (1 Ord Class A & 1/2 War)'s other metric pages and overview cover the third.